2023 Cardio-Oncology Symposium

Friday, April 28, 2023


This conference has already taken place.


The Ohio State University Medical Center - Columbus, OH
1 Day Conference April 28th, 2023
7.00 AMA PRA Category 1 Credit Hours

Description

The 2023 Cardio-Oncology Symposium addresses important clinical topics relevant to the cardiovascular health of patients with cancer. The symposium faculty will discuss new cancer treatments and strategies in diagnosis and management of cardiovascular disease in cancer patients from early diagnosis, treatment and long-term surveillance.  It is anticipated that this CME activity will Improve care for cardio-oncology patients by understanding the short-term and delayed onset cardiotoxic effects of emerging cancer therapies. In addition, identifying when cardiovascular disease issues develop with cancer patient treatment strategies can be implemented more promptly.  Case scenarios will be central to this educational activity.

REGISTRATION FOR THIS SYMPOSIUM IS CLOSED.  FOR FURTHER INFORMATION ABOUT REGISTRATION COMMUNICATE WITH THE CONTACT LISTED BELOW.

All current registrants have been sent an email from Ellen Yokoyama with the login link for this symposium. If you cannot find that email or are experiencing issues accessing the symposium platform, please email virtual.support@bartha.com.

Dates and Times

Start: 4/28/2023 7:50 AM
End: 4/28/2023 4:15 PM

Objectives

At the conclusion of the continuing medical education activity participants should be able to:

1. Define the short-term and long-term cardiotoxic effects of contemporary cancer therapies.
2. Identify the best strategies to recognize when cardiovascular issues develop with your cancer patient.
3. Describe the role of cardioprotective therapy in your cancer patient population.
4. Compare cardiac imaging modalities to determine the optimal test for specific cancer patients.
5. Identify and integrate emerging cardio-oncology guidelines in clinical practice.
6. Recognize advancements and challenges in diagnosing and managing cardiac amyloidosis.

Agenda

Agenda
Moderators: Daniel Addison, MD and Bhuvaneswari Ramaswamy, MD, MRCP
Module 1
7:50 am     Welcome and housekeeping remarks
                           Ayesha Hasan, MD and Raphael Pollock, MD, PhD

8:00           Managing Acute Coronary Syndromes in Cancer Patients
                          Dean Boudoulas, MD

8:15           Cardiac Ablation Therapy in Cancer Patients
                           Mahmoud Houmsse, MD

8:30           Cardiotoxicity after Cellular (CAR-T Cell) Therapies
                          Jonathan Brammer, MD

8:45           BTK inhibitor-induced Cardiac Arrhythmias
                          Adam Kittai, MD

9:00           Uses of STRAIN Imaging in Patients with Cancer
                          Adam Potter, MD

9:15            Addressing Cardiovascular Risk in Diverse Prostate Cancer Populations
                          Avirup Guha, MD, RPVI

9:30            Preventing and Managing Radiation associated CVD
                          Eric Miller, MD, PhD

9:45            Break

Module 2
10:00           Cardiovascular Toxicities of Immune Checkpoint Inhibitors
                           Ajay Vallakati, MBBS

10:15           Emerging Mechanisms of Tyrosine Kinase Inhibitor Cardiac Toxicity
                          Sakima Smith, MD, MPH

10:30           Managing Chronic CAD in the Cancer Patient
                          Richard Gumina, MD, PhD

10:45           Addressing Disparities in Cardio-Oncology Populations
                          Arnethea Sutton, PhD

11:00           Use of Advanced Cardiac Imaging in the Cancer Patient
                          Daniel Addison, MD

11:15           Managing Hypertension associated with Cancer Therapies
                         Jason Prosek, MD

11:30           Cardio-Oncology Needs from the Perspective of an Oncologist
                         Bhuvaneswari Ramaswamy, MD, MRCP

11:45           New Insights into the role of CHIP mutations and the Risk of Cardiovascular Disease
                         Uma Borate, MD, MS

12:00 pm     LUNCH

Module 3
Breakout Sessions:
12:55 pm   Welcome and housekeeping – Dr. Addison

Breakout A – Cardiac Complications of Cancer Immune Therapies – emerging role of Imaging
                 Avirup Guha, MD, MPH, Alma Habib, MD, Alexa Meara, MD, Paaladinesh Thavendiranathan, MD

1:00         Case Scenario (immune Checkpoint Myocarditis)
                    Alma Habib, MD

1:05         Case Scenario (CAR-T cell induced heart failure)
                     Alma Habib, MD
 
1:10          Panel Discussion 
                    Avirup Guha, MD, Alma Habib, MD, Alexa Meara, MD, Paaladinesh Thavendiranathan, MD

1:30         Keynote Lecture: Cardiac Complications of Cancer Immune Therapy: The Role of Imaging
                    Paaladinesh Thavendiranathan, MD

Breakout B – Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities
              Daniel Addison, MD, Nausheen Akhter, MD, Jonathan Brammer, MD, Benjamin Buck, MD, and Mahmoud Houmsse, MD

2:00         Case Scenarios (BTKI associated Atrial Fibrillation)
                      Benjamin Buck, MD 

2:05         Case Scenarios (Stem cell transplant associated heart failure) 
                      Benjamin Buck, MD

2:10         Panel Discussion:
                     Daniel Addison, MD, Nausheen Akhter, MD, Jonathan Brammer, MD, Benjamin Buck, MD, and Mahmoud Houmsse, MD

2:30         Keynote Lecture: Novel Targeted Therapy associated cardiotoxicities- how do we screen and management these events?
                    Nausheen Akhter, MD

3:00        Break

Breakout C – Cardiac Amyloidosis in the 21st Century
                Zachary Braunstein, MD, Naresh Bumma, MD, Courtney Campbell, MD PhD, and, Ajay Vallakati, MBBS

3:15        Case Scenarios (Indeterminate PYP Imaging, and course of care)
                      Zachary Braunstein, MD 

3:20        Case Scenarios (CHF in Myeloma, and Orthopedic associations)
                      Zachary Braunstein, MD

3:25       Panel Discussion:
                   Naresh Bumma, MD, Courtney Campbell, MD, PhD 

3:45       Keynote: New Directions in Cardiac Amyloidosis Treatment 
                    Ajay Vallakati, MBBS

4:15      Meeting Adjournment
                   Daniel Addison, MD

Pricing

Tier Price
Physician, attending in person $0.00
Nurse/Nurse Practitioner, attending in person $0.00
Allied Medical Professional, attending in person $0.00
Other, attending in person $0.00
Physician. participating online $0.00
Nurse/Nurse Practitioner, participating online $0.00
Allied Health Professional, participating online $0.00
Other, participating online $0.00

Speakers

  • Dr. Daniel Addison, MD
    • Cardiac Amyloidosis in the 21st Century - Panel Discussion
    • Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities - Panel Discussion
    • Use of Advanced Cardiac Imaging in the Cancer Patient
  • Dr. Nausheen Ahkter, MD
    • Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities - Panel Discussion
    • Novel Targeted Therapy associated cardiotoxicities- how do we screen and management these events?
  • Dr. Uma Borate, MD
    • New Insights into the role of CHIP mutations and the Risk of Cardiovascular Disease
  • Dr. Konstantinos Boudoulas, MD
    • Managing Acute Coronary Syndromes in Cancer Patients
  • Dr. Jonathan Brammer, MD
    • Cardiotoxicity after Cellular (CAR-T Cell) Therapies
    • Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities - Panel Discussion
  • Dr. Zachary Braunstein, MD
    • Cardiac Amyloidosis in the 21st Century - Case Scenarios (CHF in Myeloma, and Orthopedic associations)
    • Cardiac Amyloidosis in the 21st Century - Case Scenarios (Indeterminate PYP Imaging, and course of care)
  • Dr. Benjamin Buck, MD
    • Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities - Case Scenarios (BTKI associated Atrial Fibrillation)
    • Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities - Case Scenarios (Stem cell transplant associated heart failure)
  • Dr. Courtney Campbell, MD
    • Cardiac Amyloidosis in the 21st Century - Panel Discussion
  • Dr. Avirup Guha, MBBS
    • Addressing Cardiovascular Risk in Diverse Prostate Cancer Populations
  • Dr. Richard Gumina, MD
    • Managing Chronic CAD in the Cancer Patient
  • Dr. Alma Habib, MD
    • Case Scenario (CAR-T cell induced heart failure) - Case Scenario (CAR-T cell induced heart failure)
    • Case Scenario (CAR-T cell induced heart failure) - Case Scenario (immune Checkpoint Myocarditis)
    • Case Scenario (CAR-T cell induced heart failure) - Panel Discussion of Cases
  • Dr. Mahmoud Houmsse, MD
    • Cardiac Ablation Therapy in Cancer Patients
    • Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities - Panel Discussion
  • Dr. Adam Kittai, MD
    • BTK inhibitor-induced Cardiac Arrhythmias
  • Dr. Alexa Meara, MD
    • Case Scenario (CAR-T cell induced heart failure) - Panel Discussion of Cases
  • Dr. Eric Miller, MD
    • Preventing and Managing Radiation associated CVD
  • Dr. Adam Potter, MD
    • Uses of STRAIN Imaging in Patients with Cancer
  • Dr. Jason Prosek, MD
    • Managing Hypertension associated with Cancer Therapies
  • Dr. Bhuvaneswari Ramaswamy, MD
    • Cardio-Oncology Needs from the Perspective of an Oncologist
  • Dr. Sakima Smith, MD
    • Emerging Mechanisms of Tyrosine Kinase Inhibitor Cardiac Toxicity
  • Dr. Arnethea Sutton, PhD
    • Addressing Disparities in Cardio-Oncology Populations
  • Mr. Paaladinesh Thavendiranathan, MD
    • Cardiac Complications of Cancer Immune Therapies- the role of Imaging
  • Dr. Ajay Vallakati, MD
    • Cardiovascular Toxicities of Immune Checkpoint Inhibitors
    • Case Scenario (CAR-T cell induced heart failure) - Panel Discussion of Cases
    • Keynote Lecture: New Directions in Cardiac Amyloidosis Treatment

Location

The Ohio State University Medical Center
Biological Research Tower
460 W. 12th Avenue
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this conference?

Please contact the conference coordinator listed below:

Ellen Yokoyama
Department: Heart and Vascular Center
Phone: (614) 293-7161
Email: Ellen.Yokoyama@osumc.edu